$CSDX News

CS Group (OTCQB: CSDX) Appoints Shah Teelani & Associates, a Dubai-Based PCAOB Auditor, to Consolidate All 2025 Financial Statements for CSDX, CS Interpharm GT LLC and CS Diagnostics Pharma GmbH

CS Group (OTCQB: CSDX) Secures Strategic Manufacturing Partnerships, Accelerating Global Commercial Launch of MEDUSA SDP Hygiene Products

CS Diagnostics Picks DHL for MEDUSA SDP Rollout Might Change The Case For Investing In Deutsche Post (XTRA:DHL)

Deutsche Post (XTRA:DHL) Valuation Check As DHL Wins CS Diagnostics Global MEDUSA SDP Logistics Role

CS Interpharm and CS Diagnostics Pharma Complete Conversion of Preferred Shares to Common Stock, Strengthening CSDX's Path to Consolidated Financial Reporting

CS Diagnostics Corp. Launches Regulation D, Rule 506(c) Investment Offering

CS Diagnostics Corp. (OTCQB: CSDX) Accelerates Global Expansion with Key Regulatory Milestones and Record Growth

CS Diagnostics Corp. Submits Patent Application For CS-Protect Hydrogel in the US Market

CS Diagnostics Corp. Submitted Final Form-10 Registration Statement Draft to the processing team for preparation of Edgardization and filing with the U.S. Securities and Exchange Commission ("SEC")

CS Group Announces Strategic MOU Between CS Interpharm and Gulf Center Group for Customized Manufacturing Collaboration

Small Cap Virtual Investor Conference: Now Available for Online Viewing

CS Diagnostics Corp. to Present at the Small Cap Growth Virtual Investor Conference June 26th

CS Diagnostics Corp. CSDX to Present at the Small Cap Growth Virtual Investor Conference on June 26, 2025 at 12:30pm EDT

CS Group Announces the Valuation of MEDUSA Surface Disinfectant at USD 513 Million

CS Diagnostics Corp. is Entering into a $5 Million Loan Agreement with SAN ART CAPITAL SAS

OTCQB-CSDX Appoints Lachman Consultants for CS-Protect Hydrogel FDA Approval

CS Diagnostics Corp. Announces U.S. Launch of MEDUSA